Advertisement

Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices

Published:November 16, 2020DOI:https://doi.org/10.1016/j.hrthm.2020.11.012

      Background

      There is no consensus regarding the optimal management of cardiovascular implantable electronic device (CIED)–related superior vena cava (SVC) syndrome.

      Objective

      We report our experience with transvenous lead extractions (TLEs) in the setting of symptomatic CIED-related SVC syndrome.

      Methods

      We reviewed all TLEs performed at a high-volume center over a 14-year period and identified patients in which TLE was performed for symptomatic SVC syndrome. Patient characteristics, extraction details, percutaneous management of SVC occlusions, and clinical follow up data were analyzed.

      Results

      Over a 14-year period, more than 1600 TLEs were performed. Of these, 16 patients underwent TLE for symptomatic SVC syndrome. The mean age was 53.1 ± 12.8 years, and 9 (56.3%) were men. Thirty-seven leads, with a mean dwell time of 5.8 years (range 2–12 years), were extracted. After extraction, 6 patients (37.5%) received an SVC stent. Balloon angioplasty was performed before stenting in 5 cases (31.3%). There was 1 major complication (6.3%) due to an SVC tear that was managed surgically with a favorable outcome. Eleven patients underwent reimplantation of a CIED. Over a median follow-up of 5.5 years (interquartile range 2.0–8.5 years), 12 patients (75%) remained free of symptoms.

      Conclusion

      Combining TLE with the percutaneous treatment of symptomatic SVC syndrome is a safe and viable treatment strategy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kusumoto F.M.
        • Schoenfeld M.H.
        • Wilkoff B.L.
        • et al.
        2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.
        Heart Rhythm. 2017; 14: e503-e551
        • Rozmus G.
        • Daubert J.P.
        • Huang D.T.
        • Rosero S.
        • Hall B.
        • Francis C.
        Venous thrombosis and stenosis after implantation of pacemakers and defibrillators.
        J Interv Card Electrophysiol. 2005; 13: 9-19
        • Spittell P.C.
        • Hayes D.L.
        Venous complications after insertion of a transvenous pacemaker.
        Mayo Clin Proc. 1992; 67: 258-265
        • Oginosawa Y.
        • Abe H.
        • Nakashima Y.
        The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads.
        Pacing Clin Electrophysiol. 2002; 25: 1605-1611
        • De Costa S.S.
        • Scalabrini N.A.
        • Costa R.
        • Caldas J.G.
        • Martinelli F.M.
        Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study.
        Pacing Clin Electrophysiol. 2002; 25: 1301-1306
        • Mazzetti H.
        • Dussaut A.
        • Tenori C.
        • Dussaut E.
        • Lazzari J.O.
        Superior vena cava occlusion and/or syndrome related to pacemaker leads.
        Am Heart J. 1993; 125: 831-837
        • Goudevenos J.A.
        • Reid P.G.
        • Adams P.C.
        • Holden M.P.
        • Williams D.O.
        Pacemaker-induced superior vena cava syndrome: report of four cases and review of literature.
        Pacing Clin Electrophysiol. 1989; 12: 1890-1895
        • Riley R.F.
        • Petersen S.E.
        • Ferguson J.D.
        • Bashir Y.
        Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice.
        Pacing Clin Electrophysiol. 2010; 33: 420-425
        • Wilkoff B.L.
        • Love C.J.
        • Byrd C.L.
        • et al.
        Transvenous lead extraction: Heart Rhythm Society Expert consensus on facilities, training, indications, and patient management.
        Heart Rhythm. 2009; 6: 1085-1104
        • Wazni O.
        • Epstein L.M.
        • Carrillo R.G.
        • et al.
        Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions.
        J Am Coll Cardiol. 2010; 9: 579-586
        • Jones S.O.
        • Eckart R.E.
        • Albert C.M.
        • Epstein L.M.
        Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications.
        Heart Rhythm. 2008; 5: 520-525
        • Gray B.H.
        • Olin J.W.
        • Graor R.A.
        • Young J.R.
        • Bartholomew J.R.
        • Ruschhaupt W.F.
        Safety and efficacy of thrombolytic therapy for superior vena cava syndrome.
        Chest. 1991; 99: 54-59
        • Asif A.
        • Salman L.
        • Carrillo R.G.
        • et al.
        Patency rates for angioplasty in the treatment of pacemaker-induced central venous stenosis in hemodialysis patients: results of a multi-center study.
        Semin Dial. 2009; 22: 671-676
        • Gebreyes A.
        • Pant H.N.
        • Williams D.
        • Kuehl S.
        Be aware of wires in the veins: a case of superior vena cava syndrome in a patient with a permanent pacemaker.
        J Community Hosp Intern Med Perspect. 2012; 2
        • Zucchelli G.
        • Favilli E.
        • Viani S.
        • et al.
        Leadless pacing in a patient with superior vena cava syndrome undergoing lead extraction and percutaneous angioplasty.
        J Cardiol Cases. 2018; 17: 212-214
        • Chang S.
        • Chen J.Y.
        • Chang K.C.
        • Huang S.
        Massive thrombotic occlusion of the superior vena cava caused by a single pacemaker permanent lead successfully treated by percutaneous venoplasty.
        J Cardiovasc Electrophysiol. 2010; 21: 714-715
        • Senthilvel E.
        • Papadakis A.
        • Jain V.
        • Bruner J.
        Pacemaker induced superior vena cava syndrome: a case report.
        Cases J. 2009; 2: 6463
        • Newall N.
        • Stables R.
        • Palmer N.
        • Ramsdale D.
        Treatment of superior vena cava obstruction following permanent pacemaker extraction.
        Pacing Clin Electrophysiol. 2002; 25: 1780-1783
        • Lanciego C.
        • Rodriguez M.
        • Rodriguez A.
        • Carbonell M.A.
        • Garcìa L.G.
        Permanent pacemaker-induced superior vena cava syndrome: successful treatment by endovascular stent.
        Cardiovasc Intervent Radiol. 2003; 26: 576-579
        • Francis C.M.
        • Starkey I.R.
        • Errington M.L.
        • Gillespie I.N.
        Venous stenting as treatment for pacemaker-induced superior vena cava syndrome.
        Am Heart J. 1995; 129: 836-837
        • Slonim S.M.
        • Semba C.P.
        • Sze D.Y.
        • Dake M.D.
        Placement of SVC stents over pacemaker wires for treatment of SVC syndrome.
        J Vasc Interv Radiol. 2000; 11: 512-519
        • Gilard M.
        • Perennes A.
        • Mansourati J.
        • et al.
        Stent implantation for the treatment of superior vena cava syndrome related to pacemaker leads.
        Europace. 2002; 4: 155-158
        • Aryana A.
        • Sobota K.
        • Esterbrooks D.
        • Gelbman A.
        Superior vena cava syndrome induced by endocardial defibrillator and pacemaker leads.
        Am J Cardiol. 2007; 99: 1765-1767
        • Bakir I.
        • La Meir M.
        • Degrieck I.
        • Marien C.
        • Van Den Hauwe K.
        • Wellens F.
        Contralateral replacement of pacemaker and leads following laser sheath extraction and concomitant stenting for superior vena cava syndrome.
        Pacing Clin Electrophysiol. 2005; 28: 1131-1134
        • Fu H.
        • Huang X.
        • Zhong Li
        • et al.
        Outcome and management of pacemaker-induced superior vena cava syndrome.
        Pacing Clin Electrophysiol. 2014; 37: 1470-1476
        • Rosenthal E.
        • Qureshi S.A.
        • Tyann M.
        • Bucknall C.A.
        Percutaneous pacemaker lead extraction and stent implantation for superior vena cava occlusion due to pacemaker leads.
        Am J Cardiol. 1996; 15: 670-672
        • Bolad M.
        • Karanam S.
        • Mathew D.
        • John R.
        • Piemonte T.
        • Martin D.
        Percutaneous treatment of superior vena cava obstruction following transvenous device implantation.
        Catheter Cardiovasc Interv. 2005; 65: 64-69
        • Garlitski A.C.
        • Swingle J.D.
        • Aizer A.
        • Holmes D.S.
        • Bernstein N.E.
        • Chinitz L.A.
        Percutaneous treatment of the superior vena cava syndrome via an excimer laser sheath in a patient with a single chamber atrial pacemaker.
        J Interv Card Electrophysiol. 2006; 16: 203-206
        • Lindsay H.S.
        • Chennells P.M.
        • Perrins E.J.
        Successful treatment by balloon venoplasty and stent insertion of obstruction of the superior vena cava by an endocardial pacemaker lead.
        Br Heart J. 1994; 71: 363-365
        • Chan A.W.
        • Bhatt D.L.
        • Wilkoff B.L.
        • et al.
        Percutaneous treatment for pacemaker-associated superior vena cave syndrome.
        Pacing Clin Electrophysiol. 2002; 25: 1628-1633
        • Klop B.
        • Scheffer M.G.
        • McFadden E.
        • Bracke F.
        • van Gelder B.
        Treatment of pacemaker-induced superior vena cava syndrome by balloon angioplasty and stenting.
        Neth Heart J. 2011; 19: 41-46
        • Sohal M.
        • Williams S.
        • Akhtar M.
        • et al.
        Laser lead extraction to facilitate cardiac implantable electronic device upgrade and revision in the presence of central venous obstruction.
        Europace. 2014; 16: 81-86
        • Smayra T.
        • Otal P.
        • Chabbert V.
        • et al.
        Long-term results of endovascular stent placement in the superior caval venous system.
        Cardiovasc Intervent Radiol. 2001; 24: 388-394
      1. Arora Y, Carrillo RG. Lead related superior vena cava syndrome: management and outcomes [published online ahead of print September 11, 2020]. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2020.09.006.